Bain Capital Specialty Finance stock
BCSFNYSEBain Capital Specialty Finance, Inc., Financial ServicesISIN US05684B1070
63Score 63 out of 100, Neutral
Price and trend
55 / 100
Price history
−21% in one yearThe chart shows daily closes over 8 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 10% below it.
Since April 2025 the 50-day line has been below the 200-day line; the trend has turned down.
Overheated: the price has risen very quickly lately (RSI 72).
The price is 24% below its 52-week high. Largest decline in 8 years: 65% (March 2019 to April 2020).
Chart figures for advanced users
- SMA 50$10.93
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$12.34
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)72
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$10.05
- The lowest closing price of the last twelve months.
- Resistance$14.60
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Bain Capital Specialty Finance, Inc. belongs to the Asset Management industry (United States) and, with a market value of $717.45M, is number 101 of 131 companies in its industry on MEQIRI.
- In fiscal 2025 it earned $98.76M (down 17.3% year on year).
- For fiscal 2026, analysts expect on average adjusted earnings per share of $1.64 (down 12.8%).
Show more
- MEQIRI Score 63 out of 100 (Neutral): rank 646 of 980 in Financial Services, median 68.
- The P/E is 11.2 (Asset Management median 14, own median of recent years 9.3).
- Our model puts fair value at $17.86, with the price 37% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings per share growingUp 61.1% a year since 2020.Growth 100
- Below fair valuePrice 37% below the fair value of $17.86.Valuation 97
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 71
Weaknesses
- Dividend at riskDividend yield 15.2%. At yields this high (15% or more), the dividend was cut by at least a fifth within a year in 69 of 100 cases from 2011 to 2025, against 7 of 100 at 2 to 4%.Capital allocation 30
- Analysts expect falling earningsDown 12.9% a year through 2028 (estimates from 3 analysts).
- Dividend not coveredPayouts over the last 12 months were 170% of earnings.Capital allocation 30
Its standout strengths are growth and valuation, while profitability and capital allocation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
The fundamentals are strong overall.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- high growth grade (crashed more often in the backtest)
What lowers it
- calm price action
Valuation
Valuation signal
Significantly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $14.89 and expensive above $22.33 (uncertainty low, based on the price swings of the past year).
The two parts of the fair value come to $21.93 (excess return model) and $13.80 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $16.04, at 7.8% it would be $20.60.
Valuation metrics
Half from the excess return model, half from earnings times the industry P/E (14).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 40% on the twelve months before. Revenue has grown strongly since 2016, at around 71% per year.
Margins
- Operating margin
- Net margin
In fiscal 2025: operating 76%, net 41%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out.
Debt & balance sheet
latest quarterFor banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.
Earnings
- Next earnings
- 25 Feb 2027in 104 days
- Last reported
- 9 Nov 2026EPS reported $0.43 (expected $0.43)in line with expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $1.640.0%
- Revenue
- $249.76M0.0%
- Earnings per share
- $1.340.0%
- Revenue
- $235.86M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: −2.3%No guidance: the dividend level will be reevaluated in the coming quarters, with no direction indicated.
“We remain focused on providing an attractive dividend level to our shareholders, and we plan to reevaluate that dividend level in the coming quarters, considering factors such as the interest rate environment, upcoming debt maturities of our lower cost unsecured notes and other income sources as new M&A deal volume …”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 11 Aug 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
- Rusnak-Carlson SabrinaPurchase
3 Mar 2026, General Counsel
- Shares
- 2,300
- Price
- $12.55
- Value
- $28,865
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Bain Capital Specialty Finance
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
980 rated companies in Financial Services
- This company
- 63
- Sector median
- 68
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Asset Management
The next larger and next smaller companies by market value
- Mutares SE & Co. KGaAMUX.DE $823.8M55
- Burford CapitalBUR $801.52M38
- Carlyle Secured LendingCGBD $775.32M61
- Fidus InvestmentFDUS $742.77M67
- Investment AB Öresund (publ)ORES.ST $712.15M76
- PennantPark Floating Rate CapitalPFLT $674.68M57
- New Mountain FinanceNMFC $639.44M41
- SvolderSVOL-B.ST $633.64M53
ETFs that hold Bain Capital Specialty Finance
Held by 1 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares Listed Private Equity UCITS ETFIQQL | 0.22% | 0.75% | €683.78M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 15 May 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.